Surgical Reduction of Fibrous Tuberosity Template

Surgical reduction of fibrous tuberosity.

RMH: Medical history reviewed/updates
Vitals: BP/pulse; other vitals if indicated

Side: Side
Indication: Indication/diagnosis
Radiographs/images: Radiographs/images reviewed/taken and findings
Prosthesis fabrication.
Inadequate interarch space.
Tissue hyperplasia.

Consent: Consent/PARQ reviewed; signed/verbally obtained

Anesthesia: Anesthetic used
Carps: Carpules/amount

Surgical procedure support: Specific site/teeth, indication, and medical necessity
Operative details: Surgical access, tissue/bone removed or repositioned, closure materials
Image/specimen support: Radiographs/photos/specimen/lab as applicable

Procedure:
Incision made over tuberosity.
Fibrous tissue excised.
Underlying bone evaluated.
Excess soft tissue removed.
Adequate interarch space verified.
Wound edges approximated.
Sutured with: Suture material/size
Hemostasis achieved.

Complications: None or describe.

Patient tolerance: Tolerance/response.

Post-op instructions: Instructions reviewed.
Rx: Prescription or none

NV: Next visit

Documentation requirements

Pre-prosthetic surgical procedures are scrutinized by carriers because they are usually billed alongside a denture or implant prosthesis and the prosthetic claim's medical necessity depends on the surgical claim's documentation. The oral surgery chapter and AAOMS pre-prosthetic surgery parameters both call out a specific documentation set; missing any of these items invites denials and recoding to an alveoloplasty or denture-adjustment code. A defensible D7972 note must contain:

• Date of service and start/stop time — pre-prosthetic procedures are often performed at the same visit as impressions or denture insertions; chart time even when the dental claim does not require it.
• Medical and dental history reviewed — including anticoagulant therapy (warfarin, DOACs, antiplatelets), bleeding disorders, immunosuppression, anti-resorptive or antiangiogenic therapy (MRONJ risk on the maxillary tuberosity is lower than the mandible but not zero), prior head/neck radiation, diabetes (wound healing), and smoking status.
• Vitals — pre-op BP and pulse; post-op vitals when extended visit, sedation, or significant anesthetic volume.
• Prosthetic plan / indication — explicit documentation that the procedure is being performed to enable a specific prosthesis: new complete denture (D5110 / D5120), immediate denture (D5130 / D5140), partial denture, overdenture, implant-supported prosthesis, or relief of an existing denture that is unwearable because of tuberosity bulk. The chart should name the planned or existing prosthesis. A D7972 chart that does not connect the procedure to a prosthetic plan reads as elective and is frequently denied.
• Side / anatomical location — right or left maxillary tuberosity (or bilateral). When bilateral, document both sides; some carriers pay D7972 once per arch and others once per quadrant. Anatomical precision matters.
• Pre-op clinical findings — bulbous, redundant, or hyperplastic tuberosity; mobile fibrous tissue on palpation; degree of undercut palatal to ridge crest; interarch clearance measurement (mm) with the opposing arch in occlusion or with the existing denture in place. The pre-op interarch measurement is the single most important objective finding because it documents the functional problem the procedure is correcting.
• Tissue character — soft vs bony — explicit objective finding that the tuberosity bulk is fibrous / soft tissue and not predominantly bony. Phrases that defuse the D7485-vs-D7972 audit question: "tuberosity bulk is fibrous / soft tissue on palpation, no significant underlying bony prominence noted radiographically or on direct visualization at surgery." When bone is also reduced, the correct code is D7485.
• Radiographic / image review — panoramic radiograph (D0330), CBCT (D0364-D0368), or periapical of the tuberosity area to confirm absence of significant bony enlargement, to evaluate maxillary sinus pneumatization (the maxillary sinus floor often dips into the tuberosity area and can be perforated during reduction — a recognized complication), and to identify retained roots or other pathology. Document the imaging reviewed and one-line interpretation.
• Pre-op intraoral photograph(s) — at minimum one occlusal / lateral view of the tuberosity in the mouth, ideally with the opposing arch or existing denture in place to show the interarch problem. Photos are persuasive on appeal and a near-universal expectation in pre-prosthetic surgery practice.
• Consent / PARQ — signed or verbally obtained. PARQ should cover rationale (need to reduce tuberosity to enable the planned prosthesis), alternatives (continued attempts at denture relief, accept reduced denture extension, refer to OMFS), risks (bleeding, infection, swelling, scarring, dehiscence, maxillary sinus perforation [a recognized complication when the sinus floor extends into the tuberosity], hematoma, recurrence of fibrous tissue, need for additional surgery, possible osseous reduction at a later date if bone is also limiting), and the post-operative healing timeline before the prosthesis can be fabricated or relined (typically 4-6 weeks for soft-tissue maturation).
• Anesthesia — topical agent, local anesthetic agent and concentration, vasoconstrictor, technique (PSA block, greater palatine block, infiltration), and carpule count. Document landmarks and negative aspirations; the posterior superior alveolar artery is in the surgical field.
• Surgical method — explicit confirmation that the procedure is soft-tissue only (wedge or elliptical excision of fibrous tissue). Document the incision design (typically an elliptical or wedge incision that converges palatally and buccally to allow primary closure), the instruments used (#15 blade, electrosurgery, laser), and the volume / dimensions of tissue removed. The wedge-excision technique is the textbook approach and a defensible chart should describe it explicitly.
• Underlying bone evaluated — explicit statement that after fibrous tissue removal the underlying bone was inspected and found to be acceptable (no significant bony prominence requiring reduction, no exposed bone with sharp edges, no sinus communication). This statement is what distinguishes a D7972 from a procedure that should have been coded D7485.
• Hemostasis — how it was achieved (pressure, electrocautery, sutures, hemostatic agent). The PSA artery is in the surgical field; bleeding management deserves explicit documentation.
• Closure — primary closure with sutures, suture material and size (typically 3-0 or 4-0 chromic gut, plain gut, silk, or polyglycolic acid), and number of sutures placed. Resorbable sutures are common; document the suture-removal plan if non-resorbable.
• Specimen disposition — best practice is to send any excised tissue to pathology even when the indication is pre-prosthetic. When sent, document the pathology lab and tracking. The pathology submission alone does not convert the procedure into a biopsy (D7286/D7287); the indication remains pre-prosthetic and D7972 is the correct code.
• Interarch space verified — explicit post-op measurement (mm) confirming that adequate interarch clearance has been achieved for the planned prosthesis. This is the functional outcome the procedure was performed to achieve and is the closing objective finding for the chart.
• Complications — explicit "None" or describe (excessive bleeding, sinus perforation [requires Valsalva test and primary closure technique change to prevent oroantral fistula], hematoma, accidental sampling of adjacent structures).
• Patient tolerance and response — tolerated well, mild discomfort managed, etc. Note post-op vitals if extended visit or sedation.
• Post-op instructions — soft / cool diet 24-48 hours, avoid spicy / hot / acidic foods, gentle salt-water rinses starting tomorrow, expected mild bleeding for 24 hours, NSAID regimen, return precautions for prolonged bleeding / increasing pain / swelling / fever / nasal regurgitation of fluids (sinus communication red flag), suture-removal plan if non-resorbable. Specific to maxillary surgery: avoid forceful nose-blowing / sneezing through closed nose for 7-10 days to protect any thinned sinus membrane.
• Prescription — analgesic regimen and antibiotic if indicated (antibiotics are not routinely needed for clean intraoral procedures in healthy patients but may be appropriate for diabetic, immunocompromised, or large-defect cases).
• Next visit — post-op soft-tissue check at 1-2 weeks; impressions or denture-fabrication step typically 4-6 weeks post-op when soft-tissue is fully matured.
• Provider signature and assistant initials — required.

Two phrases that defuse the most common D7972 audit question: an explicit "tuberosity bulk is fibrous / soft tissue; underlying bone evaluated and acceptable, no osseous reduction performed" line, and an explicit "procedure performed to enable [named planned prosthesis]" line. Together they confirm code selection (D7972 vs D7485) and medical necessity (pre-prosthetic indication).

Common denial reasons

D7972 has its own denial pattern, distinct from extraction or biopsy codes. The most frequent reasons it is denied, downgraded, or recouped:

• No documented prosthetic indication — D7972 is a pre-prosthetic procedure; absent a documented planned or existing prosthesis (denture, partial, overdenture, implant prosthesis), carriers commonly deny as not medically necessary or as cosmetic.
• Recoded to D7970 (hyperplastic tissue, per arch) — when the chart describes "hyperplastic tissue" without specifying the tuberosity, carriers recode to the more general code. Explicitly identify the tuberosity as the surgical site.
• Recoded to D7485 (osseous tuberosity reduction) — uncommon as a denial direction (D7485 is generally a higher fee), but carriers may recode if the chart describes bony recontouring. When the procedure is genuinely soft-tissue only, the chart must say so explicitly.
• Submitted with D7485 same site same DOS — automatic edit rejection. The two codes are mutually exclusive on the same anatomical site.
• Submitted as bilateral with single-arch reimbursement only — many carriers pay D7972 once per arch regardless of unilateral vs bilateral involvement. Billing two units for a bilateral procedure is frequently downgraded to one.
• No pre-op clinical findings documented — chart that does not document the bulbous tuberosity, interarch interference, mobile fibrous tissue, or measured interarch space supports denial as no demonstrated medical necessity.
• No imaging reviewed — many carriers expect a panoramic or CBCT review for any pre-prosthetic surgery on the maxillary tuberosity (sinus proximity is the safety concern). Absent imaging review documentation, claims may be deferred.
• No pre-op photograph documented — increasingly cited by reviewers as a missing element. Pre-op photos document the functional problem.
• PARQ missing the sinus-perforation contingency — consent that does not include possibility of maxillary sinus perforation, oroantral communication, or need for additional surgery supports a malpractice claim if a sinus complication occurs.
• No interarch clearance measurement (pre-op or post-op) — interarch space is the functional metric that justifies the procedure; absent the measurement, reviewers question whether the procedure was needed.
• Same-lifetime repeat D7972 within a short interval — when D7972 is billed twice within a lifetime cap or short look-back window, the second claim is typically denied. Document any unusual circumstance (regrowth, partial initial reduction with planned staged completion) on the second claim.
• Wrong site labeled in chart — billing D7972 for a vestibular fibroma, alveolar ridge hyperplasia, or non-tuberosity tissue is a code-selection error. The tuberosity is a specific anatomical region; non-tuberosity hyperplasia is D7970.
• Cosmetic framing — language suggesting the indication is patient preference rather than prosthetic enablement (e.g., "patient bothered by appearance of palate") supports denial as cosmetic. Frame as enabling a specific named prosthesis.
• Practice-level audit triggers — elevated D7972 frequency without corresponding denture or implant-prosthesis claims, D7972-to-D7485 ratios that read as downcoded osseous procedures, and absent post-op denture-fabrication encounters all draw chart audits.

Related templates